1. Home
  2. WAL vs QGEN Comparison

WAL vs QGEN Comparison

Compare WAL & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$72.02

Market Cap

9.6B

Sector

Finance

ML Signal

HOLD

Logo Qiagen N.V.

QGEN

Qiagen N.V.

HOLD

Current Price

$40.87

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAL
QGEN
Founded
1994
1986
Country
United States
Netherlands
Employees
3524
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
10.2B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
WAL
QGEN
Price
$72.02
$40.87
Analyst Decision
Buy
Buy
Analyst Count
16
9
Target Price
$94.13
$51.30
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
2.33%
5.87%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.25
$8.18
Revenue Next Year
$8.09
$5.66
P/E Ratio
$10.88
$24.01
Revenue Growth
N/A
N/A
52 Week Low
$57.15
$38.58
52 Week High
$97.23
$57.82

Technical Indicators

Market Signals
Indicator
WAL
QGEN
Relative Strength Index (RSI) 45.49 41.52
Support Level $69.49 N/A
Resistance Level $81.14 $48.60
Average True Range (ATR) 2.02 0.88
MACD 1.10 0.33
Stochastic Oscillator 90.72 80.83

Price Performance

Historical Comparison
WAL
QGEN

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: